{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T14:46:52Z","timestamp":1782139612514,"version":"3.54.5"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T00:00:00Z","timestamp":1590105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T00:00:00Z","timestamp":1590105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s11239-020-02147-y","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T08:02:35Z","timestamp":1590134555000},"page":"763-771","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Drug-induced disseminated intravascular coagulation: a pharmacovigilance study on World Health Organization\u2019s database"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3302-1460","authenticated-orcid":false,"given":"Giulia","family":"Bonaldo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Vaccheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Melis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Motola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,22]]},"reference":[{"key":"2147_CR1","volume-title":"Goodman & Gilman's the pharmacological basis of therapeutics","author":"L Brunton","year":"2012","unstructured":"Brunton L, Chabner BA, Knollman B (2012) Goodman & Gilman's the pharmacological basis of therapeutics, 12th edn. McGraw-Hill Education\/Medical, New York","edition":"12"},{"key":"2147_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-0735-x","author":"S Gando","year":"2015","unstructured":"Gando S, Otomo Y (2015) Local hemostasis, immunothrombosis, and systemic disseminated intravascular coagulation in trauma and traumatic shock. Crit Care. https:\/\/doi.org\/10.1186\/s13054-015-0735-x","journal-title":"Crit Care"},{"key":"2147_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/2052-0492-2-15","author":"H Wada","year":"2014","unstructured":"Wada H, Matsumoto T, Yamashita Y (2014) Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines. J Intensive Care. https:\/\/doi.org\/10.1186\/2052-0492-2-15","journal-title":"J Intensive Care"},{"key":"2147_CR4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908193410807","author":"M Levi","year":"1999","unstructured":"Levi M, Ten Cate H (1999) Disseminated Intravascular Coagulation. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJM199908193410807","journal-title":"N Engl J Med"},{"key":"2147_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24314","author":"NW Liles","year":"2016","unstructured":"Liles NW, Page EE, Liles AL et al (2016) Diversity and severity of adverse reactions to quinine: a systematic review. Am J Hematol. https:\/\/doi.org\/10.1002\/ajh.24314","journal-title":"Am J Hematol"},{"key":"2147_CR6","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-20586","author":"SR White","year":"2002","unstructured":"White SR (2002) Amphetamine toxicity. Semin Respir Crit Care Med. https:\/\/doi.org\/10.1055\/s-2002-20586","journal-title":"Semin Respir Crit Care Med"},{"key":"2147_CR7","unstructured":"The WHO Programme for International Drug Monitoring. https:\/\/www.who.int\/medicines\/areas\/quality_safety\/safety_efficacy\/National_PV_Centres_Map\/en\/. Accessed 22 Nov 2019"},{"key":"2147_CR8","unstructured":"European Medicine Agency (2017) Guideline on good pharmacovigilance practices (GVP). https:\/\/www.ema.europa.eu\/en\/documents\/regulatory-procedural-guideline\/guideline-good-pharmacovigilance-practices-gvp-module-vi-collection-management-submission-reports_en.pdf"},{"key":"2147_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","volume":"20","author":"EG Brown","year":"1999","unstructured":"Brown EG, Wood L, Wood S (1999) Drug-safety 20:109. https:\/\/doi.org\/10.2165\/00002018-199920020-00002","journal-title":"Drug-safety"},{"key":"2147_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13234","author":"L Monaco","year":"2017","unstructured":"Monaco L, Biagi C, Conti V et al (2017) Safety profile of the direct oral anticoagulants: an analysis of WHO database of adverse drug reactions. Br J Clin Pharmacol. https:\/\/doi.org\/10.1111\/bcp.13234","journal-title":"Br J Clin Pharmacol"},{"key":"2147_CR11","unstructured":"Shibata A, Hauben M (2011) Pharmacovigilance, signal detection and signal intelligence overview. In Information fusion (FUSION). In: Proceedings of the 14th international conference, Chicago, IL, USA, July 5\u20138 2011. IEEE, New York, NY, pp 1\u20137"},{"key":"2147_CR12","unstructured":"Italian Medicine Agency (2016) Report. https:\/\/www.agenziafarmaco.gov.it\/wscs_render_attachment_by_id\/111.28397.11666135094017ecc.pdf. Accessed 22\/01\/2018"},{"issue":"5","key":"2147_CR13","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/S0016-5085(19)33015-X","volume":"65","author":"R Clark","year":"1973","unstructured":"Clark R, Borirakchanyavat V, Gazzard BG et al (1973) Disorderd hemostasis in liver damage from paracetamol overdose. Gastroenterology 65(5):788\u2013795","journal-title":"Gastroenterology"},{"key":"2147_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-011-0242-2","author":"A Mizota","year":"2011","unstructured":"Mizota A, Shitara K, Kondo C et al (2011) A case of heavily pretreated rectal cancer with disseminated intravascular coagulation that improved following reintroduction of FOLFOX plus bevacizumab. Int J Clin Oncol. https:\/\/doi.org\/10.1007\/s10147-011-0242-2","journal-title":"Int J Clin Oncol"},{"issue":"5","key":"2147_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1159\/000471844","volume":"62","author":"M Waddle","year":"2017","unstructured":"Waddle M, Irvin M, Gupta E et al (2017) Acute disseminated intravascular coagulation after oxaliplatin infusion. Chemotherapy 62(5):295\u2013300. https:\/\/doi.org\/10.1159\/000471844","journal-title":"Chemotherapy"},{"issue":"7","key":"2147_CR16","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1310\/hpj5107-564","volume":"51","author":"J Marler","year":"2016","unstructured":"Marler J, Usery JB, Nolan S et al (2016) antithrombotic usage patterns in the era of new oral anticoagulant options for atrial fibrillation. Hosp Pharm 51(7):564\u2013571. https:\/\/doi.org\/10.1310\/hpj5107-564","journal-title":"Hosp Pharm"},{"key":"2147_CR17","doi-asserted-by":"publisher","first-page":"31477","DOI":"10.1038\/srep31477","volume":"6","author":"L Staerk","year":"2016","unstructured":"Staerk L, Fosb\u00f8l EL, Gadsb\u00f8ll K et al (2016) Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: temporal trends 2011\u20132015 in Denmark. Sci Rep 6:31477. https:\/\/doi.org\/10.1038\/srep31477","journal-title":"Sci Rep"},{"issue":"5","key":"2147_CR18","doi-asserted-by":"publisher","first-page":"e4688","DOI":"10.7759\/cureus.4688","volume":"11","author":"S Piedra Abusharar","year":"2019","unstructured":"Piedra Abusharar S, Shah N, Patel R et al (2019) A case of confirmed ceftriaxone-induced immune thrombocytopenia. Cureus 11(5):e4688. https:\/\/doi.org\/10.7759\/cureus.4688","journal-title":"Cureus"},{"key":"2147_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-012-1321-7","author":"C Biagi","year":"2013","unstructured":"Biagi C, Montanaro N, Buccellato E et al (2013) Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia\u2013Romagna region). Eur J Clin Pharmacol. https:\/\/doi.org\/10.1007\/s00228-012-1321-7","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02147-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-020-02147-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02147-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T23:04:09Z","timestamp":1621638249000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-020-02147-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,22]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["2147"],"URL":"https:\/\/doi.org\/10.1007\/s11239-020-02147-y","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,22]]},"assertion":[{"value":"22 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the Authors declare that they have no conflict of interest. This manuscript has no founding source.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The manuscript does not contain clinical studies or patient data. For this type of study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}